.
MergerLinks Header Logo

Announced

Completed

Smith+Nephew completed the acquisition of the Extremity Orthopaedics business of Integra LifeSciences for $240m.

Financials

Edit Data
Transaction Value£187m
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales2.7x
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Acquisition

Cross Border

Medical Supplies

Disposal

United States

Private

Single Bidder

orthopaedic products

Majority

Friendly

Completed

Synopsis

Edit

Smith+Nephew, the global medical technology business, completed the acquisition of the Extremity Orthopaedics business of Integra LifeSciences, a global medical technology company, for $240m. "We are excited to secure this established global business in the rapidly growing extremities segment. Its portfolio, specialised sales channel and product pipeline all strengthen our business and we look forward to welcoming our new colleagues to Smith+Nephew," Skip Kiil, Smith+Nephew Global Orthopaedics President.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US